IL17 Receptor B anticorps (Middle Region)
Aperçu rapide pour IL17 Receptor B anticorps (Middle Region) (ABIN453128)
Antigène
Voir toutes IL17 Receptor B (IL17RB) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- This antibody reacts to IL17RB.
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogène
- KLH conjugated synthetic peptide selected from the Center region of human IL17RB
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- IL17 Receptor B (IL17RB) (Interleukin 17 Receptor B (IL17RB))
-
Autre désignation
- IL17RB / IL17BR
-
Sujet
- IL17RB is a cytokine receptor. This receptor specifically binds to IL17B and IL17E, but does not bind to IL17 and IL17C. This receptor has been shown to mediate the activation of NF-kappaB and the production of IL8 induced by IL17E.Synonyms: Cytokine receptor CRL4, EVI27, IL-17 receptor B, IL-17 receptor homolog 1, IL-17RB, Interleukin-17 receptor B, Interleukin-17B receptor
-
ID gène
- 55540
-
NCBI Accession
- NP_061195
-
UniProt
- Q9NRM6
Antigène
-